000136804 001__ 136804
000136804 005__ 20240229105100.0
000136804 0247_ $$2doi$$a10.1007/s00228-018-2445-1
000136804 0247_ $$2pmid$$apmid:29623360
000136804 0247_ $$2ISSN$$a0031-6970
000136804 0247_ $$2ISSN$$a1432-1041
000136804 037__ $$aDKFZ-2018-01242
000136804 041__ $$aeng
000136804 082__ $$a610
000136804 1001_ $$0P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aSchöttker, Ben$$b0$$eFirst author$$udkfz
000136804 245__ $$aUpdated analysis on polypharmacy and mortality from the ESTHER study.
000136804 260__ $$aBerlin$$bSpringer$$c2018
000136804 3367_ $$2DRIVER$$aarticle
000136804 3367_ $$2DataCite$$aOutput Types/Journal article
000136804 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1536302072_16664
000136804 3367_ $$2BibTeX$$aARTICLE
000136804 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000136804 3367_ $$00$$2EndNote$$aJournal Article
000136804 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000136804 588__ $$aDataset connected to CrossRef, PubMed,
000136804 7001_ $$0P:(DE-He78)358cd16fe1dd16be6e4eaf0e76e5ad57$$aMuhlack, Dana Clarissa$$b1$$udkfz
000136804 7001_ $$0P:(DE-He78)747b703d2a306c4276ea9e4ee9b5fe44$$aHoppe, Liesa$$b2$$udkfz
000136804 7001_ $$aHolleczek, Bernd$$b3
000136804 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b4$$eLast author$$udkfz
000136804 773__ $$0PERI:(DE-600)1459058-x$$a10.1007/s00228-018-2445-1$$gVol. 74, no. 7, p. 981 - 982$$n7$$p981 - 982$$tEuropean journal of clinical pharmacology$$v74$$x1432-1041$$y2018
000136804 909CO $$ooai:inrepo02.dkfz.de:136804$$pVDB
000136804 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000136804 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)358cd16fe1dd16be6e4eaf0e76e5ad57$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000136804 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)747b703d2a306c4276ea9e4ee9b5fe44$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000136804 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000136804 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000136804 9141_ $$y2018
000136804 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000136804 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000136804 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000136804 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000136804 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J CLIN PHARMACOL : 2015
000136804 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000136804 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000136804 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000136804 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000136804 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000136804 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000136804 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000136804 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000136804 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000136804 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000136804 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x0
000136804 9201_ $$0I:(DE-He78)G110-20160331$$kG110$$lPräventive Onkologie$$x1
000136804 980__ $$ajournal
000136804 980__ $$aVDB
000136804 980__ $$aI:(DE-He78)C070-20160331
000136804 980__ $$aI:(DE-He78)G110-20160331
000136804 980__ $$aUNRESTRICTED